Mingchao Xie

1.0k citations
14 papers · 165 indexed · h-index 9
Topics
Lung Cancer Research Studies (8 papers)Cancer therapeutics and mechanisms (4 papers)Cell death mechanisms and regulation (3 papers)
Partner nations
United StatesSpainJapan

In The Last Decade

Mingchao Xie

14 papers receiving 164 citations

Peers

Mingchao Xie
Comparison fields: 5 of 42
  • Oncology 103
  • Molecular Biology 65
  • Pulmonary and Respiratory Medicine 53
  • Epidemiology 50
  • Cancer Research 28
Replace Loreall Pooler with:
Loreall Pooler United States
Victoria Damerell South Africa
Kerstie Johnson United Kingdom
Dagmara Dymerska Poland
Marta Ferreira Portugal
Lok-Hei Chan United States
Lotus Yung United States
Eli Grunblatt United States
Hui-Wen Weng China
Junko Ohtani Japan
Mingchao Xie relative to Loreall Pooler United States Loreall Pooler's profile →
Citations per field
00.5×6.3×
Loreall Pooler · 1×
Citations per year

Countries citing papers authored by Mingchao Xie

Since Specialization
Citations

This map shows the geographic impact of Mingchao Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingchao Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingchao Xie more than expected).

Fields of papers citing papers by Mingchao Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingchao Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingchao Xie. The network helps show where Mingchao Xie may publish in the future.

Co-authorship network of co-authors of Mingchao Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Mingchao Xie. A scholar is included among the top collaborators of Mingchao Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingchao Xie. Mingchao Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 1
2 5
3 28
4 17
5 3
6 1
7 10
8 17
9 2
10 12
11 39
12 9
13 13
14 8

About Mingchao Xie

Mingchao Xie is a scholar working on Oncology, Biomaterials and Cancer Research, having authored 14 papers that have together received 165 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (8 papers), Cancer therapeutics and mechanisms (4 papers) and Cell death mechanisms and regulation (3 papers). The work is most often cited by research in Oncology (103 citations), Cancer Research (28 citations) and Pulmonary and Respiratory Medicine (53 citations). Mingchao Xie has collaborated with scholars based in United States, Spain and Japan. Frequent co-authors include Zhongwu Lai, Elizabeth A. Harrington, Darren Hodgson, Yashaswi Shrestha, Ethan S. Sokol, Luis Paz‐Ares, J. Carl Barrett, Jonathan R. Dry, Michael J. Monument and Shangfeng Liu. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026